Simplex Trading’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,418
| Closed | -$6.1K | – | 10454 |
|
|
2025
Q4 | $6.1K | Sell |
1,418
-1,570
| -53% | -$14.1K | ﹤0.01% | 7312 |
|
|
2025
Q3 | $116K | Buy |
+2,988
| New | +$85.1K | ﹤0.01% | 5579 |
|
|
2025
Q1 | – | Sell |
-45
| Closed | – | – | 9946 |
|
|
2024
Q4 | $0 | Buy |
45
+36
| +400% | +$392 | ﹤0.01% | 9861 |
|
|
2024
Q3 | $0 | Sell |
9
-94
| -91% | -$1.1K | ﹤0.01% | 9807 |
|
|
2024
Q2 | $0 | Sell |
103
-26
| -20% | -$620 | ﹤0.01% | 10039 |
|
|
2024
Q1 | $4K | Buy |
129
+118
| +1,073% | +$3.06K | ﹤0.01% | 8183 |
|
|
2023
Q4 | $0 | Sell |
11
-94
| -90% | -$3.89K | ﹤0.01% | 10048 |
|
|
2023
Q3 | $6K | Sell |
105
-539
| -84% | -$50.6K | ﹤0.01% | 7590 |
|
|
2023
Q2 | $65K | Buy |
644
+567
| +736% | +$78.1K | ﹤0.01% | 5563 |
|
|
2023
Q1 | $13K | Buy |
77
+48
| +166% | +$16.1K | ﹤0.01% | 7344 |
|
|
2022
Q4 | $11K | Sell |
29
-228
| -89% | -$86.6K | ﹤0.01% | 7487 |
|
|
2022
Q3 | $86K | Buy |
257
+51
| +25% | +$18.5K | ﹤0.01% | 5733 |
|
|
2022
Q2 | $67K | Buy |
206
+190
| +1,188% | +$66.7K | ﹤0.01% | 6111 |
|
|
2022
Q1 | $7K | Sell |
16
-108
| -87% | -$44.3K | ﹤0.01% | 9226 |
|
|
2021
Q4 | $54K | Buy |
+124
| New | +$62.3K | ﹤0.01% | 7172 |
|
|
2021
Q2 | – | Sell |
-192
| Closed | -$122K | – | 10843 |
|
|
2021
Q1 | $149K | Sell |
192
-571
| -75% | -$391K | ﹤0.01% | 5193 |
|
|
2020
Q4 | $415K | Buy |
763
+542
| +245% | +$284K | ﹤0.01% | 3673 |
|
|
2020
Q3 | $101K | Sell |
221
-146
| -40% | -$84.8K | ﹤0.01% | 4900 |
|
|
2020
Q2 | $226K | Buy |
367
+134
| +58% | +$74K | ﹤0.01% | 3858 |
|
|
2020
Q1 | $110K | Sell |
233
-1
| -0.4% | -$543 | ﹤0.01% | 4273 |
|
|
2019
Q4 | $135K | Buy |
234
+50
| +27% | +$35.1K | ﹤0.01% | 4183 |
|
|
2019
Q3 | $121K | Buy |
+184
| New | +$153K | ﹤0.01% | 4116 |
|
|
2019
Q2 | – | Sell |
-15
| Closed | -$10.5K | – | 7941 |
|
|
2019
Q1 | $10K | Sell |
15
-400
| -96% | -$239K | ﹤0.01% | 6169 |
|
|
2018
Q4 | $194K | Sell |
415
-104
| -20% | -$67.1K | ﹤0.01% | 3192 |
|
|
2018
Q3 | $447K | Buy |
+519
| New | +$375K | ﹤0.01% | 2753 |
|
|
2018
Q1 | – | Sell |
-352
| Closed | -$171K | – | 7008 |
|
|
2017
Q4 | $154K | Buy |
352
+341
| +3,100% | +$155K | 0.01% | 1484 |
|
|
2017
Q3 | $5K | Sell |
11
-204
| -95% | -$102K | ﹤0.01% | 4445 |
|
|
2017
Q2 | $119K | Buy |
215
+160
| +291% | +$102K | 0.01% | 1609 |
|
|
2017
Q1 | $36K | Sell |
55
-29
| -35% | -$15.5K | ﹤0.01% | 2674 |
|
|
2016
Q4 | $28K | Buy |
+84
| New | +$27K | ﹤0.01% | 2737 |
|
|
2016
Q2 | – | Sell |
-190
| Closed | -$41.4K | – | 6566 |
|
|
2016
Q1 | $42K | Buy |
+190
| New | +$56.8K | ﹤0.01% | 2114 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
Simplex Trading's TVRD Position: Q1 2026 in Review
Simplex Trading sold out of Tvardi Therapeutics (TVRD) in Q1 2026, closing a stake of 1,418 shares — an estimated $6.1K sold.
Simplex Trading first reported a position in TVRD in Q1 2016 and held it in 31 quarters. The position peaked at $447K in Q3 2018. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- Simplex Trading reported no remaining Tvardi Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 1,418 Tvardi Therapeutics shares in Q1 2026, an estimated $6.1K.
- Simplex Trading first reported a position in Tvardi Therapeutics in Q1 2016 and held it in 31 quarters.
- Simplex Trading's Tvardi Therapeutics position peaked at $447K in Q3 2018.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.